Tegsedi Market Report 2026

Tegsedi Market Overview

• The Tegsedi market growth in the historic period has been driven by improved understanding of hereditary amyloidosis, expansion of genetic testing programs • Market expansion is supported by rising adoption of personalized genetic medicines, increasing demand for home-based treatment options • Growth Driver: Rising Adoption Of Personalized Medicine To Boost The Market Growth • North America was the largest region in 2025.

What Is Covered Under Tegsedi Market?

Tegsedi (inotersen) is a subcutaneous injection used to treat polyneuropathy in adults with hereditary transthyretin-mediated amyloidosis (hATTR), where amyloid proteins accumulate in tissues, leading to nerve damage. It inhibits the production of transthyretin (TTR) protein, reducing amyloid deposits and alleviating neuropathic symptoms. Administered weekly via subcutaneous injection, it offers patients a self-administered treatment option. The main indications for tegsedi are neurological manifestations, cardiac involvement, and other indications. Neurological manifestations refer to the symptoms and signs that arise from dysfunction of the nervous system, which includes the brain, spinal cord, and peripheral nerves. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies. These are used for various end-users such as hospitals, clinics, ambulatory care, and home care.

What Is The Tegsedi Market Growth Forecast?

The growth in the forecast period can be attributed to rising adoption of personalized genetic medicines, increasing demand for home-based treatment options, expansion of precision diagnostics, growing investment in rna therapeutics, advancements in long-term safety monitoring frameworks. Major trends in the forecast period include increasing adoption of rna-targeted therapies, growing preference for self-administered treatments, expansion of precision neurology medications, rising focus on disease-modifying therapies, enhanced patient monitoring and safety protocols.

Global Tegsedi Market Segmentation

1) By Indication: Neurological Manifestations, Cardiac Involvement, Other Indications 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By End User: Hospitals, Clinics, Ambulatory Care, Home Care

What Are The Drivers Of The Tegsedi Market?

The rising adoption of personalized medicine is expected to propel the growth of the tegsedi market going forward. Personalized medicine involves customizing medical treatment based on an individual's genetic profile, lifestyle, and environment for more effective outcomes. The rising adoption of personalized medicine is driven by advancements in genomic research, improved diagnostic tools, and the growing demand for more targeted and effective treatments. Personalized medicine enhances the efficacy and safety of Tegsedi by tailoring treatment to the genetic and clinical profiles of individuals with hereditary transthyretin-mediated amyloidosis, ensuring optimal therapeutic outcomes and minimizing potential risks. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the rising adoption of personalized medicine is driving the growth of the tegsedi industry. The rising healthcare expenditure is expected to propel the growth of the tegsedi market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Rising healthcare expenditure is driving broader access to innovative therapies, enabling greater adoption of Tegsedi for patients with rare genetic disorders. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the tegsedi industry.

Key Players In The Global Tegsedi Market

Major companies operating in the tegsedi market are Ionis Pharmaceuticals Inc.

What Are Latest Mergers And Acquisitions In The Tegsedi Market?

In January 2024, Acino, a Switzerland-based pharmaceutical company, partnered with Sobi for an undisclosed amount. With this partnership, Acino and Sobi aims to expand access to essential therapies, including tegsedi, for patients with rare diseases in Kazakhstan, improving treatment availability in underserved areas. Sobi is a Sweden-based biopharmaceutical company that offers tegsedi.

Regional Insights

North America was the largest region in the tegsedi market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Tegsedi Market?

The tegsedi market consists of sales of subcutaneous injection, and prefilled syringe. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Tegsedi Market Report 2026?

The tegsedi market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tegsedi industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.